Ribavirin for Chronic Hepatitis E in Liver-Transplant Setting: A Safe and Highly Effective Therapy.
*Gastroenterology Department Hospital Egas Moniz †Liver Transplantation Unit Hospital Curry Cabral ‡Molecular Biology Department-S.P.C. Hospital Curry Cabral-CHLC Lisbon, Portugal §Clinical Microbiology and Public Health Laboratory, Health Protection Agency Addenbrooke's Hospital, Cambridge, UK.
Joana
J
Carmo
Susana
S
Marques
Élia
É
Mateus
Ana
A
Morbey
Júlio
J
Veloso
Madalena
M
Almeida-Santos
Martin
M
Curran
Eduardo
E
Barroso
D000328:Adult; D028227:Amyloid Neuropathies, Familial / Q000601:surgery; D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D016174:Hepacivirus; D016751:Hepatitis E / Q000188:drug therapy*; D006521:Hepatitis, Chronic / Q000188:drug therapy*; D006527:Hepatolenticular Degeneration / Q000601:surgery; D006801:Humans; D016898:Interferon-alpha; D016031:Liver Transplantation; D012254:Ribavirin / Q000627:therapeutic use*; D016896:Treatment Outcome
D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin